Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nutex Health Inc.CLNH · Entity 4803 | Director · 10% owner | January 28, 2021 | February 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nutex Health Inc.
Report date January 28, 2021 · Filed February 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.61 · Expires 2028-01-28 | Direct | 130,120 |
Reported balance
After 2021-01-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-01-28 · Grant · Acquired 45,000 · Balance 130,120 F1: Quarterly 25%, fully vested upon change in control, fully vested upon closing of merger. |
| Common StockSEC Table I · non-derivative | Direct | 724,496 |
Reported balance
Holding disclosure · report date 2021-01-28 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 724,496 |
Filing footnotes · ownership attribution and instrument terms
F1: Quarterly 25%, fully vested upon change in control, fully vested upon closing of merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2021 Filed Feb 4, 2021 18:58 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $1.61 Strike: $1.61 | $72,450.00 |
DisclosureSEC source: 0001486189-21-000005 · primary_doc.xml · derivative · entry 2 Breslin Terence Martin · CIK 0001793402 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,120 Underlying: Common Stock · 45,000 shares Expires 2028-01-28 F1 · derivative.exercise_date: Quarterly 25%, fully vested upon change in control, fully vested upon closing of merger. Read SEC document |
| August 12, 2020 Filed Sep 9, 2020 13:24 UTC | Nutex Health Inc. CLNH · Entity 4803 | PurchaseCommon Stock | 31,746 | $20,000.00 | $634,920,000.00 |
DisclosureSEC source: 0001486189-20-000013 · primary_doc.xml · nonDerivative · entry 1 Breslin Terence Martin · CIK 0001793402 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 724,496 F1 · balance_after: Does not include 85,120 options previously reported. Read SEC document |
| May 11, 2020 Filed Jun 23, 2020 14:09 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantDirector Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000010 · primary_doc.xml · derivative · entry 1 Breslin Terence Martin · CIK 0001793402 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,120 Underlying: Common Stock · 30,000 shares Expires 2027-05-11 Read SEC document |
| January 27, 2020 Filed Apr 25, 2020 00:31 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001793402-20-000001 · primary_doc.xml · derivative · entry 1 Breslin Terence Martin · CIK 0001793402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: The options vest quarterly over a one year period with vesting to occur at the first day of each new quarter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.